Page 5 - Pipeline Overview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pipeline overview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pipeline Overview Today - Breaking & Trending Today

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Sold by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC reduced its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) by 57.3% during the 4th quarter, HoldingsChannel reports. The fund owned 52,146 shares of the company’s stock after selling 70,115 shares during the period. Moody Aldrich Partners LLC’s holdings in Axsome Therapeutics were worth $4,022,000 at the end […] ....

United States , Armstrong Advisory Group Inc , Signature Estate Investment Advisors , Moody Aldrich Partners , Axsome Therapeutics Inc , Axsome Therapeutics , Get Rating , Aldrich Partners , Wealth Management , Financial Strategies , Advisory Group , Signature Estate , Investment Advisors , Products Overview , Pipeline Overview , Visit Holdingschannel , Axsome Therapeutics Daily , Nasdaq Axsm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Down 4.3%

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) shares traded down 4.3% on Tuesday . The stock traded as low as $60.85 and last traded at $61.17. 250,168 shares changed hands during trading, a decline of 74% from the average session volume of 961,231 shares. The stock had previously closed at $63.92. Wall Street Analyst Weigh […] ....

Great West Life Assurance Co , Armstrong Advisory Group Inc , Quent Capital , Morgan Stanley , Axsome Therapeutics Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics , Get Rating , Financial Advisors , Advisory Group , Great West Life Assurance , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics (NASDAQ:AXSM) Price Target Lowered to $200.00 at HC Wainwright

Axsome Therapeutics (NASDAQ:AXSM – Get Rating) had its target price reduced by HC Wainwright from $210.00 to $200.00 in a report released on Monday morning, The Fly reports. HC Wainwright also issued estimates for Axsome Therapeutics’ Q1 2023 earnings at ($1.40) EPS, Q2 2023 earnings at ($1.40) EPS, Q3 2023 earnings at ($1.29) EPS, Q4 […] ....

United States , Piper Sandler , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Brinker Capital Investments , Health Sciences , Tower Research Capital , Axsome Therapeutics , Get Rating , Moderate Buy , Therapeutics Trading Down , Capital Investments , Research Capital , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm , Lower Price Target , Hc Wainwright ,

Q1 2023 EPS Estimates for Axsome Therapeutics, Inc. (NASDAQ:AXSM) Reduced by Analyst

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – HC Wainwright reduced their Q1 2023 EPS estimates for shares of Axsome Therapeutics in a research report issued to clients and investors on Monday, March 20th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of ($1.40) for the quarter, down […] ....

United States , Axsome Therapeutics Company Profile , Life Insurance Co , Pricet Rowe Associates Inc , Axsome Therapeutics Inc , Morgan Stanley , Group Plc , Axsome Therapeutics , Get Rating , Axsome Therapeutic , General Group Plc , Arizona State Retirement System , State Retirement System , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm , Earnings Estimates , Hc Wainwright ,

Axsome Therapeutics (NASDAQ:AXSM) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Get Rating) in a research report issued on Thursday. The brokerage set a “sell” rating on the stock. AXSM has been the topic of a number of other reports. Morgan Stanley dropped their price objective on shares of Axsome Therapeutics from $86.00 […] ....

United States , Morgan Stanley , Raymond James Financial Services Advisors Inc , Axsome Therapeutics Inc , Metlife Investment Management , Panagora Asset Management Inc , Jpmorgan Chase Co , Sei Investments Co , Axsome Therapeutics Company Profile , Axsome Therapeutics , Get Rating , Therapeutics Trading Down , James Financial Services Advisors , Life Investment Management , Asset Management , Sei Investments , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm , Initiated Coverage , Stocknews Com ,